Sparse Securities Claims Against COVID-19 Treatment Maker Again Dismissed
SAN DIEGO — Dismissal of shareholder claims in a securities class action lawsuit against a clinical-stage biopharmaceutical company and certain of its senior executives stemming from alleged misrepresentations the defendants made...To view the full article, register now.
Already a subscriber? Click here to view full article